Despite a handful of last-minute lawsuits seeking to halt the proceedings, shareholders of Ovascience Inc. gave their endorsement Dec. 4 to the reverse merger with Millendo Therapeutics Inc. Shares of the combined company, operating under the Millendo name, are expected to begin trading on the Nasdaq Capital Market Monday under the ticker MLND.